SIMPLEX TRADING, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$519
+60.2%
21,006
+83.4%
0.00%
Q2 2023$324
-4.7%
11,454
-22.8%
0.00%
Q1 2023$340
-99.9%
14,834
-6.2%
0.00%
-100.0%
Q3 2022$447,000
+106.0%
15,807
+61.1%
0.00%
Q2 2022$217,000
+55.0%
9,810
+130.3%
0.00%
Q4 2021$140,000
-56.5%
4,260
-25.5%
0.00%
Q3 2021$322,000
-20.1%
5,715
-21.9%
0.00%
Q2 2021$403,000
-30.2%
7,322
-45.1%
0.00%
-100.0%
Q4 2020$577,000
+761.2%
13,337
+596.4%
0.00%
Q3 2020$67,000
-42.2%
1,915
-12.3%
0.00%
Q2 2020$116,000
-86.7%
2,183
-91.9%
0.00%
-100.0%
Q3 2019$875,000
+1051.3%
27,037
+2286.3%
0.00%
Q1 2019$76,000
-84.8%
1,133
-89.6%
0.00%
-100.0%
Q4 2018$501,000
+47.4%
10,875
+146.2%
0.00%0.0%
Q3 2018$340,000
-83.6%
4,418
-82.1%
0.00%
-87.5%
Q2 2018$2,078,000
+56.6%
24,678
+52.0%
0.01%
-86.2%
Q1 2018$1,327,000
+232.6%
16,234
+132.1%
0.06%
+241.2%
Q4 2017$399,000
+19850.0%
6,994
+18802.7%
0.02%
Q3 2017$2,000
-85.7%
37
-89.5%
0.00%
-100.0%
Q4 2016$14,000
-99.0%
354
-98.7%
0.00%
-99.0%
Q3 2016$1,473,000
+186.0%
27,905
+126.9%
0.10%
+194.1%
Q2 2016$515,000
+27.8%
12,301
+23.8%
0.03%
+6.2%
Q1 2016$403,000
+5657.1%
9,933
+8109.1%
0.03%
+3100.0%
Q4 2015$7,000
-94.4%
121
-89.3%
0.00%
-90.0%
Q2 2015$125,000
+792.9%
1,130
+782.8%
0.01%
+400.0%
Q4 2014$14,0001280.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders